Market Cap 756.24M
Revenue (ttm) 0.00
Net Income (ttm) -57.39M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 682,100
Avg Vol 2,037,108
Day's Range N/A - N/A
Shares Out 104.89M
Stochastic %K 47%
Beta 0.44
Analysts Strong Sell
Price Target $12.80

Company Profile

Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and Sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of prader-willi syndrome, tourette syndrome, excessiv...

Industry: Biotechnology
Sector: Healthcare
Phone: 786 629 1376
Address:
2222 Ponce de Leon Blvd., Floor 3, Coral Gables, United States
teaman60
teaman60 Apr. 21 at 2:13 PM
$RLMD Someone dumping shares today. They are doing it slowly to get the most they can.
0 · Reply
teaman60
teaman60 Apr. 21 at 1:45 PM
$RLMD Rug pull? If trials go bad this is gone.
0 · Reply
shehww
shehww Apr. 20 at 10:23 AM
$RLMD 😎 🔥🔥🔥
0 · Reply
VikaDelic
VikaDelic Apr. 16 at 7:05 PM
$RLMD teamaam is all hyped up today, probably the day to add. Cheers brothers
1 · Reply
teaman60
teaman60 Apr. 16 at 5:36 PM
$RLMD Strange no one follows this ticker. Good news if the get FDA approval for me I suppose
0 · Reply
teaman60
teaman60 Apr. 16 at 2:49 PM
$RLMD Think about setting a stop loss on this. If bad news, it will tank to $2
0 · Reply
teaman60
teaman60 Apr. 15 at 4:56 PM
$RLMD Can't hold 7s,as I said it wouldn't
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 14 at 4:58 PM
$RLMD RSI: 70.17, MACD: 0.5248 Vol: 0.50, MA20: 6.72, MA50: 5.45 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
StockConsultant
StockConsultant Apr. 9 at 4:28 PM
$RLMD Relmada Therapeutics stock, edging higher with a continuation breakout at https://stockconsultant.com/?RLMD
0 · Reply
DonCorleone77
DonCorleone77 Apr. 8 at 3:38 PM
$RLMD Attached is a Mizuho analyst note regarding AVGO issued today.
0 · Reply
Latest News on RLMD
Relmada Therapeutics Earnings Call Transcript: Q4 2025

Mar 19, 2026, 4:30 PM EDT - 5 weeks ago

Relmada Therapeutics Earnings Call Transcript: Q4 2025


Relmada Therapeutics Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 5 months ago

Relmada Therapeutics Earnings Call Transcript: Q3 2025


Relmada Therapeutics Transcript: Small-Cap Virtual Conference

Sep 18, 2025, 10:00 AM EDT - 7 months ago

Relmada Therapeutics Transcript: Small-Cap Virtual Conference


Relmada Issues Mid-Year CEO Letter to Shareholders

Sep 10, 2025, 7:15 AM EDT - 8 months ago

Relmada Issues Mid-Year CEO Letter to Shareholders


Relmada Therapeutics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 9 months ago

Relmada Therapeutics Earnings Call Transcript: Q2 2025


Relmada Therapeutics Earnings Call Transcript: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Relmada Therapeutics Earnings Call Transcript: Q1 2025


Relmada Therapeutics Transcript: Status Update

Apr 28, 2025, 4:30 PM EDT - 1 year ago

Relmada Therapeutics Transcript: Status Update


Relmada Therapeutics to Host KOL Event on Phase 2 NDV-01 Data

Apr 24, 2025, 8:00 AM EDT - 1 year ago

Relmada Therapeutics to Host KOL Event on Phase 2 NDV-01 Data


Relmada Therapeutics To Present NDV-01 Data at AUA2025

Apr 14, 2025, 7:30 AM EDT - 1 year ago

Relmada Therapeutics To Present NDV-01 Data at AUA2025


Relmada Therapeutics Earnings Call Transcript: Q4 2024

Mar 27, 2025, 4:30 PM EDT - 1 year ago

Relmada Therapeutics Earnings Call Transcript: Q4 2024


Relmada Therapeutics Earnings Call Transcript: Q3 2024

Nov 7, 2024, 4:30 PM EST - 1 year ago

Relmada Therapeutics Earnings Call Transcript: Q3 2024


Relmada Therapeutics Earnings Call Transcript: Q2 2024

Aug 7, 2024, 4:30 PM EDT - 1 year ago

Relmada Therapeutics Earnings Call Transcript: Q2 2024


Relmada Therapeutics Earnings Call Transcript: Q1 2024

May 8, 2024, 4:30 PM EDT - 2 years ago

Relmada Therapeutics Earnings Call Transcript: Q1 2024


Relmada Therapeutics Earnings Call Transcript: Q4 2023

Mar 19, 2024, 4:30 PM EDT - 2 years ago

Relmada Therapeutics Earnings Call Transcript: Q4 2023


Relmada Therapeutics Earnings Call Transcript: Q3 2023

Nov 8, 2023, 4:30 PM EST - 2 years ago

Relmada Therapeutics Earnings Call Transcript: Q3 2023


Relmada Therapeutics Earnings Call Transcript: Q2 2023

Aug 8, 2023, 4:30 PM EDT - 2 years ago

Relmada Therapeutics Earnings Call Transcript: Q2 2023


Relmada Therapeutics Earnings Call Transcript: Q1 2023

May 11, 2023, 4:30 PM EDT - 3 years ago

Relmada Therapeutics Earnings Call Transcript: Q1 2023


Relmada Therapeutics Earnings Call Transcript: Q4 2022

Mar 23, 2023, 4:30 PM EDT - 3 years ago

Relmada Therapeutics Earnings Call Transcript: Q4 2022


Relmada Therapeutics Transcript: Study Result

Dec 7, 2022, 5:00 PM EST - 3 years ago

Relmada Therapeutics Transcript: Study Result


Relmada Therapeutics Earnings Call Transcript: Q3 2022

Nov 10, 2022, 4:30 PM EST - 3 years ago

Relmada Therapeutics Earnings Call Transcript: Q3 2022


Relmada Therapeutics Earnings Call Transcript: Q2 2022

Aug 11, 2022, 4:30 PM EDT - 4 years ago

Relmada Therapeutics Earnings Call Transcript: Q2 2022


Relmada Therapeutics Earnings Call Transcript: Q1 2022

May 5, 2022, 4:30 PM EDT - 4 years ago

Relmada Therapeutics Earnings Call Transcript: Q1 2022


Relmada Therapeutics Earnings Call Transcript: Q4 2021

Mar 23, 2022, 4:30 PM EDT - 4 years ago

Relmada Therapeutics Earnings Call Transcript: Q4 2021


Relmada Therapeutics Transcript: Study Result

Feb 23, 2022, 8:30 AM EST - 4 years ago

Relmada Therapeutics Transcript: Study Result


Relmada Therapeutics Earnings Call Transcript: Q3 2021

Nov 11, 2021, 4:30 PM EST - 4 years ago

Relmada Therapeutics Earnings Call Transcript: Q3 2021


Relmada Therapeutics Earnings Call Transcript: Q2 2021

Aug 10, 2021, 4:30 PM EDT - 5 years ago

Relmada Therapeutics Earnings Call Transcript: Q2 2021


Relmada Therapeutics Transcript: Study Result

Jul 27, 2021, 8:30 AM EDT - 5 years ago

Relmada Therapeutics Transcript: Study Result


Relmada Therapeutics Earnings Call Transcript: Q1 2021

May 12, 2021, 4:30 PM EDT - 5 years ago

Relmada Therapeutics Earnings Call Transcript: Q1 2021


Relmada Therapeutics Earnings Call Transcript: Q4 2020

Mar 23, 2021, 4:30 PM EDT - 5 years ago

Relmada Therapeutics Earnings Call Transcript: Q4 2020


teaman60
teaman60 Apr. 21 at 2:13 PM
$RLMD Someone dumping shares today. They are doing it slowly to get the most they can.
0 · Reply
teaman60
teaman60 Apr. 21 at 1:45 PM
$RLMD Rug pull? If trials go bad this is gone.
0 · Reply
shehww
shehww Apr. 20 at 10:23 AM
$RLMD 😎 🔥🔥🔥
0 · Reply
VikaDelic
VikaDelic Apr. 16 at 7:05 PM
$RLMD teamaam is all hyped up today, probably the day to add. Cheers brothers
1 · Reply
teaman60
teaman60 Apr. 16 at 5:36 PM
$RLMD Strange no one follows this ticker. Good news if the get FDA approval for me I suppose
0 · Reply
teaman60
teaman60 Apr. 16 at 2:49 PM
$RLMD Think about setting a stop loss on this. If bad news, it will tank to $2
0 · Reply
teaman60
teaman60 Apr. 15 at 4:56 PM
$RLMD Can't hold 7s,as I said it wouldn't
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 14 at 4:58 PM
$RLMD RSI: 70.17, MACD: 0.5248 Vol: 0.50, MA20: 6.72, MA50: 5.45 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
StockConsultant
StockConsultant Apr. 9 at 4:28 PM
$RLMD Relmada Therapeutics stock, edging higher with a continuation breakout at https://stockconsultant.com/?RLMD
0 · Reply
DonCorleone77
DonCorleone77 Apr. 8 at 3:38 PM
$RLMD Attached is a Mizuho analyst note regarding AVGO issued today.
0 · Reply
teaman60
teaman60 Apr. 7 at 1:48 PM
$RLMD No buyers and I was proven correct that it couldn't hold $7
2 · Reply
teaman60
teaman60 Apr. 1 at 6:53 PM
$RLMD Too bad couldn't hold the gain today. Will close under 7 I believe
1 · Reply
shehww
shehww Apr. 1 at 1:42 PM
$RLMD 8+ 🔥🔥🔥🚀🚀🚀💥💥💥🔥🔥🔥
0 · Reply
shehww
shehww Mar. 31 at 7:44 PM
$RLMD soon $8+
0 · Reply
shehww
shehww Mar. 30 at 3:09 PM
0 · Reply
shehww
shehww Mar. 25 at 2:19 PM
$RLMD 😎 🔥🔥🔥💥💥💥🚀🚀🚀
0 · Reply
AStrokeOfLuck
AStrokeOfLuck Mar. 24 at 6:37 PM
0 · Reply
shehww
shehww Mar. 24 at 4:26 PM
$RLMD 😂
0 · Reply
teaman60
teaman60 Mar. 23 at 6:32 PM
$RLMD low 5s by April 1
0 · Reply
shehww
shehww Mar. 23 at 4:58 PM
0 · Reply
IN0V8
IN0V8 Mar. 20 at 4:10 PM
$RLMD Watch / Opportunity Mizuho raises target price to $19 from $10
0 · Reply
anachartanalyst
anachartanalyst Mar. 20 at 2:01 PM
$RLMD https://anachart.com/wp-content/uploads/ana_temp/1774015290_soc-img.jpg
0 · Reply